Muvon
muvon.io
Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Octofs 0.9.0: Line 42 Is a Lie
Octofs 0.9.0 gives every line a content-verified composite ID (N:hh) that edit tools check before touching a file, so a stale target fails loudly with the fresh content instead of silently editing the wrong line. Plus replace_all and CRLF-safe matching in
Read more
Report
MUVON Therapeutics Reports Positive Phase 2 Results for its First-in-Class Muscle Precursor Cell (MPC)-based Tissue-Engineered Therapy Showing Clinically Meaningful and ...
Read more
Report
Muvon Therapeutics AG: MUVON Therapeutics Reports Positive Phase 2 Results for its First-in-Class Muscle Precursor Cell (MPC)-based Tissue-Engineered Therapy Showing Clinically Meaningful and Statistically Significant Benefits in Stress Urinary Incon...
Zurich, Switzerland, December 03, 2025 - MUVON Therapeutics AG, a clinical-stage biotechnology company, reports positive topline results from the Phase 2 clinical trial SUISSE-MPC2 ) evaluating its
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Central
Hong Kong
Regional office
Connect
Suite C, Level 7, World Trust Tower, 50 Stanley Street, Central, Hong Kong